---
schema_version: "secwatch.filing_event.v1"
accession: "0001964738-25-000062"
form_type: "8-K"
ticker: "SOLV"
cik: "0001964738"
company_name: "Solventum Corp"
filed_at: "2025-08-07T23:59:59+00:00"
generated_at: "2026-05-17T18:28:19.042146+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Solventum Q2 sales up 3.9% to $2.2B; raises FY organic growth & EPS guidance

## Summary
- GAAP diluted EPS $0.51; adjusted diluted EPS $1.69 (+8.3% YoY).
- Organic sales +2.8%; all segments positive, led by MedSurg and HIS.
- Adjusted operating margin expanded 120 bps to 21.9%.
- FY 2025 organic sales guidance raised to +2.0%-3.0%; EPS raised to $5.80-$5.95.
- Operating cash flow $169M; free cash flow $59M in Q2.

## SEC filing metadata
- accession: 0001964738-25-000062
- form_type: 8-K
- ticker: SOLV
- cik: 0001964738
- company_name: Solventum Corp
- filed_at: 2025-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1964738/000196473825000062/0001964738-25-000062-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1964738/000196473825000062/solv-20250807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001964738-25-000062
- JSON: https://secwatch.observer/filing/0001964738-25-000062.json
- Plain text: https://secwatch.observer/filing/0001964738-25-000062.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.